More on INO
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.90 |
|
|||
| Open | $0.93 | ||||
| 52 Wk High | $11.69 | ||||
| 52 Wk Low | $4.50 | ||||
| Day High | $1.10 | ||||
| Day Low | $0.90 | ||||
| P/E | N/A | ||||
| EPS | $-0.28 | ||||
| Volume | 12,214,074 | ||||
- H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)
- Jefferies Upgrades Inovio Pharmaceuticals (INO) to Buy
- Inovio Pharma (INO) Tops Q2 EPS by 18c
- Form 8-K INOVIO PHARMACEUTICALS, For: Aug 12
- INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
- Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30
- Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
- Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
- Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: FMR LLC
- INOVIO to Report Second Quarter Financial Results on August 12, 2026
Entities mentioned with INO
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- 13G | View Related Stories »
- Bill & Melinda Gates Foundation Trust | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
